More than a million Swiss fully vaccinated against Covid-19
The number of people in Switzerland who have been fully vaccinated against Covid-19 has topped the one million mark, the authorities said on Friday.
This content was published on
2 minutes
swissinfo.ch/mga
A total of 1,007,469 people have had two vaccine doses, corresponding to 11.7% of the population of 8.6 million. A similar number of people have had one jab.
Between April 29 and May 5, some 372,796 doses were administered in Switzerland at an average of 53,257 vaccinations per day. That’s an increase of 4% on the previous week.
Switzerland has been criticised for the slow start of its vaccination programme, including large discrepancies in the rate of vaccinations between cantons. The health regulator, Swissmedic, has taken more time than many other countries to approve vaccines and there have been delays in receiving some supplies.
The Swiss government has ordered nearly 36 million vaccine doses from five companies. Covid-19 vaccines from Pfizer/BioNTech and Moderna are currently being administered as others still await regulatory approval.
On Thursday the government said it had ordered a further seven million doses from Moderna for 2022, with the option of another seven million.
“Switzerland has enough vaccine in 2021 to allow children and adolescents to be vaccinated too – provided the vaccines are authorised for this target group. It has also secured a sufficient number of vaccine doses for 2022 to offer the entire population a very high level of immunisation protection,” the government saidExternal link.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
Optimism returns as Covid-19 numbers fall in Switzerland
This content was published on
The drop in new Covid-19 cases and the accelerating vaccination programme are extremely encouraging, according to a top federal health official.
Lonza to double production of Covid-19 vaccine at Swiss plant
This content was published on
The Swiss firm will add three more production lines to its plant as part of a larger effort to boost Moderna’s global supply of vaccine doses.
First case of Indian Covid-19 variant detected in Switzerland
This content was published on
The first case of the Indian variant of Covid-19 has been discovered in Switzerland, the Federal Office of Public Health has announced on Twitter.
CureVac seeks Covid-19 shot approval in Switzerland
This content was published on
German drugmaker CureVac has submitted an application for the approval of its Covid-19 vaccine with the Swiss drugs regulator.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.